Organon (OGN) Prices $1B Notes Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
May 7, 2024 8:20 PM EDTJERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) (Organon), a global healthcare company with a focus on womens health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the Co-Issuer and, together with Organon, the Companies), have priced an offering of $500 million of 6.750% senior secured notes due 2034 (the Secured Notes) and $500 million of 7.875% senior unsecured notes due 2034 (the Unsecured Notes and, together with the Secured Notes the Notes). Each series of notes will be guaranteed by each of the entities that guarantees the Companies existing... More
